Dr. Alexander Clarysse: what changed
What changed
Dr. Alexander Clarysse
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€124,621
2024 · €69,234+€55,387
Equity
€143,221
2024 · €87,834+€55,387
Cash
€70,597
2024 · €69,214+€1,383
Balance sheet total
€166,743
2024 · €114,699+€52,044
Largest movements
Assets
- Deferred charges and accrued income +€52,840
up €52,840 (+164%), from €32,260 to €85,101
- Tangible fixed assets -€2,589
down €2,589 (-22.3%), from €11,634 to €9,045
Equity and liabilities
- Reserves +€55,387
up €55,387 (+80.0%), from €69,234 to €124,621
- Other debts -€4,005
down €4,005 (-55.6%), from €7,202 to €3,197
Income statement
- Gross operating margin +€74,574
up €74,574 (+82.8%), from €90,060 to €164,634
- Taxes +€18,698
up €18,698 (+100%), from €18,611 to €37,309
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€69,234
Gross operating margin
+€74,574
Depreciation
-€166
Other operating charges
-€104
Financial income
+€521
Financial charges
-€739
Taxes
-€18,698
Result 2025
€124,621
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€70,617
Investment
€0
Financing
-€69,234
Cash 2024
€69,214
From operations (derived)
+€70,617
Net result for the year
+€124,621
Depreciation
+€2,589
Receivables within one year
-€409
Deferred charges and accrued income
-€52,840
Smaller working-capital items
+€155
Other debts
-€4,005
Accrued charges and deferred income
+€507
Financing
-€69,234
Contributions, distributions and other
-€69,234
Cash 2025
€70,597
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €114,699 | €166,743 | +€52,044 | +45.4% |
| Fixed assets | 21/28 | €11,634 | €9,045 | -€2,589 | -22.3% |
| Tangible fixed assets | 22/27 | €11,634 | €9,045 | -€2,589 | -22.3% |
| Plant, machinery and equipment | 23 | €3,063 | €2,077 | -€986 | -32.2% |
| Furniture and vehicles | 24 | €1,433 | €800 | -€633 | -44.2% |
| Other tangible fixed assets | 26 | €7,138 | €6,169 | -€970 | -13.6% |
| Current assets | 29/58 | €103,065 | €157,698 | +€54,633 | +53.0% |
| Amounts receivable within one year | 40/41 | €1,591 | €2,000 | +€409 | +25.7% |
| Trade receivables | 40 | €1,341 | €2,000 | +€659 | +49.1% |
| Other amounts receivable | 41 | €249 | - | -€249 | |
| Cash at bank and in hand | 54/58 | €69,214 | €70,597 | +€1,383 | +2.0% |
| Deferred charges and accrued income | 490/1 | €32,260 | €85,101 | +€52,840 | +164% |
| Total equity and liabilities | 10/49 | €114,699 | €166,743 | +€52,044 | +45.4% |
| Equity | 10/15 | €87,834 | €143,221 | +€55,387 | +63.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €69,234 | €124,621 | +€55,387 | +80.0% |
| Distributable reserves | 133 | €69,234 | €124,621 | +€55,387 | +80.0% |
| Amounts payable | 17/49 | €26,865 | €23,522 | -€3,343 | -12.4% |
| Amounts payable within one year | 42/48 | €26,349 | €22,499 | -€3,850 | -14.6% |
| Trade debts | 44 | €3,161 | €3,090 | -€71 | -2.2% |
| Suppliers | 440/4 | €3,161 | €3,090 | -€71 | -2.2% |
| Taxes, remuneration and social security | 45 | €15,986 | €16,212 | +€226 | +1.4% |
| Taxes | 450/3 | €15,986 | €16,212 | +€226 | +1.4% |
| Other amounts payable | 47/48 | €7,202 | €3,197 | -€4,005 | -55.6% |
| Accrued charges and deferred income | 492/3 | €516 | €1,023 | +€507 | +98.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,423 | €2,589 | +€166 | +6.9% |
| Other operating charges | 640/8 | €200 | €305 | +€104 | +52.1% |
| Gross operating margin | 9900 | €90,060 | €164,634 | +€74,574 | +82.8% |
| Operating profit (loss) | 9901 | €87,437 | €161,740 | +€74,304 | +85.0% |
| Financial income | 75/76B | €1,200 | €1,721 | +€521 | +43.4% |
| Recurring financial income | 75 | €1,200 | €1,721 | +€521 | +43.4% |
| Financial charges | 65/66B | €792 | €1,531 | +€739 | +93.3% |
| Recurring financial charges | 65 | €792 | €1,531 | +€739 | +93.3% |
| Profit (loss) for the period before taxes | 9903 | €87,845 | €161,930 | +€74,085 | +84.3% |
| Income taxes | 67/77 | €18,611 | €37,309 | +€18,698 | +100% |
| Profit (loss) for the period | 9904 | €69,234 | €124,621 | +€55,387 | +80.0% |
| Profit (loss) for the period to be appropriated | 9905 | €69,234 | €124,621 | +€55,387 | +80.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.